FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 316:1429-1435 June 4, 1987 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of severe congestive heart failure (New York Heart Association [NYHA] functional class IV), we randomly assigned 253 patients in a double-blind study to receive either placebo (n = 126) or enalapril (n = 127). Conventional treatment for heart failure, including the use of other vasodilators, was continued in both groups. Follow-up averaged 188 days (range, 1 day to 20 months). The crude mortality at the end of six months (primary end point) was 26 percent in the enalapril group and 44 percent in the placebo group--a reduction of 40 percent (P = 0.002). Mortality was reduced by 31 percent at one year (P = 0.001). By the end of the study, there had been 68 deaths in the placebo group and 50 in the enalapril group--a reduction of 27 percent (P = 0.003). The entire reduction in total mortality was found to be among patients with progressive heart failure (a reduction of 50 percent), whereas no difference was seen in the incidence of sudden cardiac death. A significant improvement in NYHA classification was observed in the enalapril group, together with a reduction in heart size and a reduced requirement for other medication for heart failure. The overall withdrawal rate was similar in both groups, but hypotension requiring withdrawal occurred in seven patients in the enalapril group and in no patients in the placebo group. After the initial dose of enalapril was reduced to 2.5 mg daily in high-risk patients, this side effect was less frequent. We conclude that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms. The beneficial effect on mortality is due to a reduction in death from the progression of heart failure.

This article has been cited by other articles:

• Crespo, M. J., Cruz, N., Altieri, P. I., Escobales, N. (2008). Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster. J CARDIOVASC PHARMACOL THER 13: 199-206 [Abstract]  
• Schindler, C. (2008). ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET. Therapeutic Advances in Cardiovascular Disease 2: 233-248 [Abstract]  
• Gutierrez, O. M., Tamez, H., Bhan, I., Zazra, J., Tonelli, M., Wolf, M., Januzzi, J. L., Chang, Y., Thadhani, R. (2008). N-terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Concentrations in Hemodialysis Patients: Prognostic Value of Baseline and Follow-up Measurements. Clin. Chem. 54: 1339-1348 [Abstract] [Full Text]  
• Ootaki, C., Yamashita, M., Ootaki, Y., Kamohara, K., Weber, S., Klatte, R. S., Smith, W. A., Massiello, A. L., Emancipator, S. N., Golding, L. A.R., Fukamachi, K. (2008). Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System. J. Thorac. Cardiovasc. Surg. 136: 150-158 [Abstract] [Full Text]  
• Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., Waldo, A. L., the Atrial Fibrillation and Congestive Heart Failu, (2008). Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. NEJM 358: 2667-2677 [Abstract] [Full Text]  
• Werner, C. M., Bohm, M. (2008). Review: The therapeutic role of RAS blockade in chronic heart failure. Therapeutic Advances in Cardiovascular Disease 2: 167-177 [Abstract]  
• Kasama, S., Toyama, T., Sumino, H., Nakazawa, M., Matsumoto, N., Sato, Y., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M. (2008). Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. JNM 49: 907-914 [Abstract] [Full Text]  
• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Beer, M., Wagner, D., Myers, J., Sandstede, J., Kostler, H., Hahn, D., Neubauer, S., Dubach, P. (2008). Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy. J Am Coll Cardiol 51: 1883-1891 [Abstract] [Full Text]  
• Eisen, H. J. (2008). Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less. J Am Coll Cardiol 51: 1892-1895 [Full Text]  
• Pilote, L. MD PhD, Abrahamowicz, M. PhD, Eisenberg, M. MD MPH, Humphries, K. DSc, Behlouli, H. MSc PhD, Tu, J. V. MD PhD (2008). Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ 178: 1303-1311 [Abstract] [Full Text]  
• McMurray, J. J.V., Pitt, B., Latini, R., Maggioni, A. P., Solomon, S. D., Keefe, D. L., Ford, J., Verma, A., Lewsey, J., for the Aliskiren Observation of Heart Failure Tre, (2008). Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure. Circ Heart Fail 1: 17-24 [Abstract] [Full Text]  
• Anand, I. S., Rector, T. S., Kuskowski, M., Thomas, S., Holwerda, N.J., Cohn, J. N. (2008). Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail 1: 34-42 [Abstract] [Full Text]  
• Katz, A. M. (2008). The "Modern" View of Heart Failure: How Did We Get Here?. Circ Heart Fail 1: 63-71 [Full Text]  
• Verjans, J. W.H., Lovhaug, D., Narula, N., Petrov, A. D., Indrevoll, B., Bjurgert, E., Krasieva, T. B., Petersen, L. B., Kindberg, G. M., Solbakken, M., Cuthbertson, A., Vannan, M. A., Reutelingsperger, C. P.M., Tromberg, B. J., Hofstra, L., Narula, J. (2008). Noninvasive Imaging of Angiotensin Receptors After Myocardial Infarction. J Am Coll Cardiol Img 1: 354-362 [Abstract] [Full Text]  
• Sharma, V., Dhillon, P., Wambolt, R., Parsons, H., Brownsey, R., Allard, M. F., McNeill, J. H. (2008). Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol. 294: H1609-H1620 [Abstract] [Full Text]  
• Coffman, T. M., Crowley, S. D. (2008). Kidney in Hypertension: Guyton Redux. Hypertension 51: 811-816 [Full Text]  
• de Resende, M. M., Amaral, S. L., Moreno, C., Greene, A. S. (2008). Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol. Genomics 33: 33-40 [Abstract] [Full Text]  
• Brunetti, L., DeSantis, E. R. H. (2008). Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm 65: 132-137 [Abstract] [Full Text]  
• Patel, N. D., Nwakanma, L. U., Weiss, E. S., Williams, J. A., Conte, J. V. (2008). Impact of Septal Myocardial Infarction on Outcomes After Surgical Ventricular Restoration. Ann. Thorac. Surg. 85: 135-146 [Abstract] [Full Text]  
• Symeonides, P., Koulouris, S., Vratsista, E., Triantafyllou, K., Ioannidis, G., Thalassinos, N., Katritsis, D. (2007). Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study. Eur J Echocardiogr 8: 480-486 [Abstract] [Full Text]  
• Triller, D. M., Hamilton, R. A. (2007). Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm 64: 2244-2249 [Abstract] [Full Text]  
• Rodriguez-Granillo, G. A., de Winter, S., Bruining, N., Ligthart, J. M.R., Garcia-Garcia, H. M., Valgimigli, M., de Feyter, P. J., on behalf of the EUROPA/PERSPECTIVE Investigators, (2007). Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study. Eur Heart J 28: 2326-2331 [Abstract] [Full Text]  
• Kitsios, G., Zintzaras, E. (2007). Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis. Am J Epidemiol 166: 619-633 [Abstract] [Full Text]  
• Saha, S. A., Molnar, J., Arora, R. R. (2007). Tissue ACE Inhibitors for Secondary Prevention of Cardiovascular Disease in Patients With Preserved Left Ventricular Function: A Pooled Meta-analysis of Randomized Placebo-controlled Trials. J CARDIOVASC PHARMACOL THER 12: 192-204 [Abstract]  
• Borer, J. S. (2007). Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseases. Eur Heart J Suppl 9: E2-E9 [Abstract] [Full Text]  
• Husser, O., Husser, D., Stridh, M., Sornmo, L., Corino, V. D.A., Mainardi, L. T., Lombardi, F., Klein, H. U., Olsson, S. B., Bollmann, A. (2007). Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation. Europace 9: 627-632 [Abstract] [Full Text]  
• Fonarow, G. C., Abraham, W. T., Albert, N. M., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Pieper, K., Sun, J. L., Yancy, C. W., Young, J. B., for the OPTIMIZE-HF Investigators and Hospitals, (2007). Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart Failure: Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 167: 1493-1502 [Abstract] [Full Text]  
• Fruhwald, F. M., Fahrleitner-Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J.-C., Cleland, J. G.F. (2007). Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J 28: 1592-1597 [Abstract] [Full Text]  
• Frohlich, E. D. (2007). The Salt Conundrum: A Hypothesis. Hypertension 50: 161-166 [Full Text]  
• Patel, J., Heywood, J. T. (2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER 12: 127-136 [Abstract]  
• Patel, N. D., Williams, J. A., Nwakanma, L. U., Weiss, E. S., Conte, J. V. (2007). Impact of Lateral Wall Myocardial Infarction on Outcomes After Surgical Ventricular Restoration. Ann. Thorac. Surg. 83: 2017-2028 [Abstract] [Full Text]  
• Fedoruk, L. M., Tribble, C. G., Kern, J. A., Peeler, B. B., Kron, I. L. (2007). Predicting Operative Mortality After Surgery for Ischemic Cardiomyopathy. Ann. Thorac. Surg. 83: 2029-2035 [Abstract] [Full Text]  
• Komajda, M., Hanon, O., Hochadel, M., Follath, F., Swedberg, K., Gitt, A., Cleland, J. G.F. (2007). Management of octogenarians hospitalized for heart failure in Euro Heart Failure Survey I. Eur Heart J 28: 1310-1318 [Abstract] [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Berghe, G. V. d., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Suppl 9: C3-C74 [Full Text]  
• Johnson, M. J (2007). Management of end stage cardiac failure. Postgrad. Med. J. 83: 395-401 [Abstract] [Full Text]  
• Fischer, M. A., Choudhry, N. K., Winkelmayer, W. C. (2007). Impact Of Medicaid Prior Authorization On Angiotensin-Receptor Blockers: Can Policy Promote Rational Prescribing?. Health Aff (Millwood) 26: 800-807 [Abstract] [Full Text]  
• Kim, S.-J., Zhang, X., Xu, X., Chen, A., Gonzalez, J. B., Koul, S., Vijayan, K., Crystal, G. J., Vatner, S. F., Hintze, T. H. (2007). Evidence for enhanced eNOS function in coronary microvessels during the second window of protection. Am. J. Physiol. Heart Circ. Physiol. 292: H2152-H2158 [Abstract] [Full Text]  
• Frazier, C. G., Alexander, K. P., Newby, L. K., Anderson, S., Iverson, E., Packer, M., Cohn, J., Goldstein, S., Douglas, P. S. (2007). Associations of Gender and Etiology With Outcomes in Heart Failure With Systolic Dysfunction: A Pooled Analysis of 5 Randomized Control Trials. J Am Coll Cardiol 49: 1450-1458 [Abstract] [Full Text]  
• Casarett, D. J., Quill, T. E. (2007). "I'm Not Ready for Hospice": Strategies for Timely and Effective Hospice Discussions. ANN INTERN MED 146: 443-449 [Abstract] [Full Text]  
• Neubauer, S. (2007). The Failing Heart -- An Engine Out of Fuel. NEJM 356: 1140-1151 [Full Text]  
• Temple, R., Stockbridge, N. L. (2007). BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective. ANN INTERN MED 146: 57-62 [Abstract] [Full Text]  
• Authors/Task Force Members, , Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., Malmberg, K., Priori, S., Ostergren, J., Tuomilehto, J., Thrainsdottir, I., Other Contributors, , Vanhorebeek, I., Stramba-Badiale, M., Lindgren, P., Qiao, Q., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Deckers, J. W., Bertrand, M., Charbonnel, B., Erdmann, E., Ferrannini, E., Flyvbjerg, A., Gohlke, H., Juanatey, J. R. G., Graham, I., Monteiro, P. F., Parhofer, K., Pyorala, K., Raz, I., Schernthaner, G., Volpe, M., Wood, D. (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28: 88-136 [Full Text]  
• Weisfeldt, M. L., Zieman, S. J. (2007). Advances In The Prevention And Treatment Of Cardiovascular Disease. Health Aff (Millwood) 26: 25-37 [Abstract] [Full Text]  
• Ceconi, C., Fox, K. M., Remme, W. J., Simoons, M. L., Bertrand, M., Parrinello, G., Kluft, C., Blann, A., Cokkinos, D., Ferrari, R. (2007). ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73: 237-246 [Abstract] [Full Text]  
• Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., Stevenson, W. (2006). The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions. Circulation 114: 2871-2891 [Full Text]  
• Werner, R. M., Bradlow, E. T. (2006). Relationship Between Medicare's Hospital Compare Performance Measures and Mortality Rates. JAMA 296: 2694-2702 [Abstract] [Full Text]  
• Horowitz, J. D., Kennedy, J. A. (2006). Time to Address the Cardiac Metabolic "Triple Whammy": Ischemic Heart Failure in Diabetic Patients. J Am Coll Cardiol 48: 2232-2234 [Full Text]  
• DeMets, D. L (2006). Futility approaches to interim monitoring by data monitoring committees. Clin Trials 3: 522-529 [Abstract]  
• Pedersen, O. D., Sondergaard, P., Nielsen, T., Nielsen, S. J., Nielsen, E. S., Falstie-Jensen, N., Nielsen, I., Kober, L., Burchardt, H., Seibaek, M., Torp-Pedersen, C., on behalf of the DIAMOND study group investigators, (2006). Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 27: 2866-2870 [Abstract] [Full Text]  
• van Campen, C M C, Visser, F C, de Cock, C C, Vos, H S, Kamp, O, Visser, C A (2006). Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation. Heart 92: 1795-1800 [Abstract] [Full Text]  
• Skali, H., Pfeffer, M. A., Lubsen, J., Solomon, S. D. (2006). Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials. Circulation 114: 2298-2303 [Abstract] [Full Text]  
• Rivero-Ayerza, M., Theuns, D. A.M.J., Garcia-Garcia, H. M., Boersma, E., Simoons, M., Jordaens, L. J. (2006). Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 27: 2682-2688 [Abstract] [Full Text]  
• Edwards, N.C., Steeds, R.P., Ferro, C.J., Townend, J.N. (2006). The treatment of coronary artery disease in patients with chronic kidney disease. QJM 99: 723-736 [Abstract] [Full Text]  
• Pfeffer, M. A., Frohlich, E. D. (2006). Improvements in clinical outcomes with the use of angiotensin-converting enzyme inhibitors: cross-fertilization between clinical and basic investigation. Am. J. Physiol. Heart Circ. Physiol. 291: H2021-H2025 [Abstract] [Full Text]  
• Hauptman, P. J., Schnitzler, M. A., Swindle, J., Burroughs, T. E. (2006). Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.. JAMA 296: 1877-1884 [Abstract] [Full Text]  
• Sarkar, P., Nicholson, G., Hall, G. (2006). Brief review: Angiotensin converting enzyme inhibitors and angioedema: anesthetic implications: [Revue sommaire sur les implications anesthesiques de l'oedeme de Quincke et des inhibiteurs de l'enzyme de conversion de l'angiotensine].. Canadian J. Anesthesia 53: 994-1003 [Abstract] [Full Text]  
• Kasama, S, Toyama, T, Hatori, T, Sumino, H, Kumakura, H, Takayama, Y, Ichikawa, S, Suzuki, T, Kurabayashi, M (2006). Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. Heart 92: 1434-1440 [Abstract] [Full Text]  
• Gheorghiade, M., Sopko, G., De Luca, L., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D. L., Rouleau, J. L., Bonow, R. O. (2006). Navigating the Crossroads of Coronary Artery Disease and Heart Failure. Circulation 114: 1202-1213 [Full Text]  
• Kirby, M. (2006). Heart failure and diabetes in primary care. British Journal of Diabetes & Vascular Disease 6: 220-228 [Abstract]  
• Dolezal, T. (2006). Review: Imidapril in Heart Failure. Journal of Renin-Angiotensin-Aldosterone System 7: 146-154 [Abstract]  
• Patel, N. D., Williams, J. A., Nwakanma, L. U., Waldron, M. M., Bluemke, D. A., Conte, J. V. (2006). Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?. Ann. Thorac. Surg. 82: 879-888 [Abstract] [Full Text]  
• Writing Committee Members, , Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 651-745 [Full Text]  
• Idanpaan-Heikkila, U. M., Lambie, L., Mattke, S., McLaughlin, V., Palmer, H., Tu, J. V. (2006). Selecting indicators for the quality of cardiac care at the health system level in Organization for Economic Co-operation and Development countries. Int J Qual Health Care 18: 39-44 [Abstract] [Full Text]  
• Tsuyuki, R. T., McDonald, M. A. (2006). Response to Tsuyuki and McDonald. Circulation 114: 855-860 [Full Text]  
• Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society . J Am Coll Cardiol 48: e149-e246 [Full Text]  
• Fuster, V., Ryden, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., Olsson, S. B., Prystowsky, E. N., Tamargo, J. L., Wann, S., ACC/AHA TASK FORCE MEMBERS, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Anderson, J. L., Antman, E. M., Halperin, J. L., Hunt, S. A., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., ESC COMMITTEE FOR PRACTICE GUIDELINES, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: e257-e354 [Full Text]  
• Cohn, J. N. (2006). Efficacy and Safety in Clinical Trials in Cardiovascular Disease. J Am Coll Cardiol 48: 430-433 [Abstract] [Full Text]  
• Solomon, S. D., Rice, M. M., A. Jablonski, K., Jose, P., Domanski, M., Sabatine, M., Gersh, B. J., Rouleau, J., Pfeffer, M. A., Braunwald, E., for the Prevention of Events with ACE inhibition (, (2006). Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial. Circulation 114: 26-31 [Abstract] [Full Text]  
• Santangelo, L., Ammendola, E., Russo, V., Cavallaro, C., Vecchione, F., Garofalo, S., D'Onofrio, A., Calabro, R. (2006). Influence of biventricular pacing on myocardial dispersion of repolarization in dilated cardiomyopathy patients. Europace 8: 502-505 [Abstract] [Full Text]  
• Arzt, M., Bradley, T. D. (2006). Treatment of Sleep Apnea in Heart Failure. Am. J. Respir. Crit. Care Med. 173: 1300-1308 [Abstract] [Full Text]  
• Lechat, P. (2006). The evolution of heart failure management over recent decades: from CONSENSUS to CIBIS. Eur Heart J Suppl 8: C5-C12 [Abstract] [Full Text]  
• Silke, B. (2006). Beta-blockade in CHF: pathophysiological considerations. Eur Heart J Suppl 8: C13-C18 [Abstract] [Full Text]  
• Funck-Brentano, C. (2006). Beta-blockade in CHF: from contraindication to indication. Eur Heart J Suppl 8: C19-C27 [Abstract] [Full Text]  
• Ponikowski, P. (2006). Rationale and design of CIBIS III. Eur Heart J Suppl 8: C35-C42 [Abstract] [Full Text]  
• Vanoli, E., Adamson, P. B. (2006). What does the future hold for the management of chronic heart failure?. Eur Heart J Suppl 8: C51-C57 [Abstract] [Full Text]  
• Kasama, S, Toyama, T, Hatori, T, Sumino, H, Kumakura, H, Takayama, Y, Ichikawa, S, Suzuki, T, Kurabayashi, M (2006). Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure. Heart 92: 625-630 [Abstract] [Full Text]  
• Mehta, P A, Cowie, M R (2006). Gender and heart failure: a population perspective. Heart 92: iii14-iii18 [Full Text]  
• Pennell, D. J., Berdoukas, V., Karagiorga, M., Ladis, V., Piga, A., Aessopos, A., Gotsis, E. D., Tanner, M. A., Smith, G. C., Westwood, M. A., Wonke, B., Galanello, R. (2006). Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107: 3738-3744 [Abstract] [Full Text]  
• Al-Mallah, M. H., Tleyjeh, I. M., Abdel-Latif, A. A., Weaver, W. D. (2006). Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Coll Cardiol 47: 1576-1583 [Abstract] [Full Text]  
• Kies, P, Leclercq, C, Bleeker, G B, Crocq, C, Molhoek, S G, Poulain, C, van Erven, L, Bootsma, M, Zeppenfeld, K, van der Wall, E E, Daubert, J-C, Schalij, M J, Bax, J J (2006). Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 92: 490-494 [Abstract] [Full Text]  
• Volpe, M., Tocci, G., Pagannone, E. (2006). Fewer Mega-Trials and More Clinically Oriented Studies in Hypertension Research? The Case of Blocking the Renin-Angiotensin-Aldosterone System.. J. Am. Soc. Nephrol. 17: S36-S43 [Abstract] [Full Text]  
• Shah, N. C, Pringle, S., Struthers, A. (2006). Aldosterone Blockade Over and Above ACE-Inhibitors in Patients with Coronary Artery Disease but without Heart Failure. Journal of Renin-Angiotensin-Aldosterone System 7: 20-30 [Abstract]  
• Feringa, H. H. H., Bax, J. J., Schouten, O., Poldermans, D. (2006). Protecting the Heart with Cardiac Medication in Patients with Left Ventricular Dysfunction Undergoing Major Noncardiac Vascular Surgery. SEMIN CARDIOTHORAC VASC ANESTH 10: 25-31 [Abstract]  
• Akbulut, T., Akgoz, H., Dayi, S. U., Celik, S. E., Gurkan, U., Tayyareci, G. (2006). Evaluation of Enalapril+Losartan Treatment with Cardiopulmonary Exercise Test in Patients with Left Ventricular Dysfunction. ANGIOLOGY 57: 181-186 [Abstract]  
• Ehrlich, J. R., Hohnloser, S. H., Nattel, S. (2006). Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27: 512-518 [Abstract] [Full Text]  
• Nickenig, G., Ostergren, J., Struijker-Boudier, H. (2006). Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers. Journal of Renin-Angiotensin-Aldosterone System 7: S1-S7 [Abstract]  
• Liu, P. P, Maggioni, A., Velazquez, E. J (2006). Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients. Journal of Renin-Angiotensin-Aldosterone System 7: S19-S22 [Abstract]  
• Berl, T., Henrich, W. (2006). Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment. CJASN 1: 8-18 [Full Text]  
• Palomeque, J., Sapia, L., Hajjar, R. J., Mattiazzi, A., Vila Petroff, M. (2006). Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK. Am. J. Physiol. Heart Circ. Physiol. 290: H96-H106 [Abstract] [Full Text]  
• Ellenbogen, K. A., Wood, M. A., Klein, H. U. (2005). Why Should We Care About CARE-HF?. J Am Coll Cardiol 46: 2199-2203 [Abstract] [Full Text]  
• Carson, P., Anand, I., O'Connor, C., Jaski, B., Steinberg, J., Lwin, A., Lindenfeld, J., Ghali, J., Barnet, J. H., Feldman, A. M., Bristow, M. R. (2005). Mode of Death in Advanced Heart Failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) Trial. J Am Coll Cardiol 46: 2329-2334 [Abstract] [Full Text]